CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Jan. 29, 2023			132,453,000
Beginning balance at Jan. 29, 2023		$ 1,701,051	$ 1,325	$ 572,455	$ 1,141,819	$ (13,809)	$ (739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		156,531			156,531
Foreign currency translation adjustments		(2,205)				(2,205)
Change in fair value of derivative financial instruments, net of tax		242				242
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(486)				(486)
Conversion/release of stock-based awards (in shares)	[1]		996,000
Conversion/release of stock-based awards	[1]	(49,518)	$ 10	(49,327)			(201)
Repurchase of common stock (in shares)	[2]		(5,005,000)
Repurchase of common stock	[2]	(302,401)	$ (50)	(14,778)	(286,573)		(1,000)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(334)	(180)		514
Stock-based compensation expense		23,282		23,282
Dividends declared		(59,671)			(59,671)
Foreign currency translation adjustments		(2,205)
Ending balance (in shares) at Apr. 30, 2023			128,444,000
Ending balance at Apr. 30, 2023		1,466,825	$ 1,285	531,298	951,926	(16,258)	(1,426)
Beginning balance (in shares) at Jan. 29, 2023			132,453,000
Beginning balance at Jan. 29, 2023		1,701,051	$ 1,325	572,455	1,141,819	(13,809)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		595,323
Foreign currency translation adjustments		(4,062)
Change in fair value of derivative financial instruments, net of tax		163
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(896)
Ending balance (in shares) at Oct. 29, 2023			128,270,000
Ending balance at Oct. 29, 2023		1,813,234	$ 1,283	571,765	1,260,216	(18,604)	(1,426)
Beginning balance (in shares) at Apr. 30, 2023			128,444,000
Beginning balance at Apr. 30, 2023		1,466,825	$ 1,285	531,298	951,926	(16,258)	(1,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		201,507			201,507
Foreign currency translation adjustments		2,171				2,171
Change in fair value of derivative financial instruments, net of tax		(157)				(157)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(296)				(296)
Conversion/release of stock-based awards (in shares)	[1]		25,000
Conversion/release of stock-based awards	[1]	(432)		(432)
Repurchase of common stock (in shares)	[2]		(180,000)
Repurchase of common stock	[2]	(10,096)	$ (2)	(547)	(9,547)
Stock-based compensation expense		20,547		20,547
Dividends declared		(59,114)			(59,114)
Foreign currency translation adjustments		2,171
Ending balance (in shares) at Jul. 30, 2023			128,289,000
Ending balance at Jul. 30, 2023		1,620,955	$ 1,283	550,866	1,084,772	(14,540)	(1,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		237,285			237,285
Foreign currency translation adjustments		(4,028)
Change in fair value of derivative financial instruments, net of tax		78				78
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(114)				(114)
Conversion/release of stock-based awards (in shares)	[1]		24,000
Conversion/release of stock-based awards	[1]	(1,159)		(1,159)
Repurchase of common stock (in shares)	[2]		(43,000)
Repurchase of common stock	[2]	(3,014)	$ 0	(131)	(2,883)
Stock-based compensation expense		22,189		22,189
Dividends declared		(58,958)			(58,958)
Foreign currency translation adjustments		(4,028)				(4,028)
Ending balance (in shares) at Oct. 29, 2023			128,270,000
Ending balance at Oct. 29, 2023		1,813,234	$ 1,283	571,765	1,260,216	(18,604)	(1,426)
Beginning balance (in shares) at Jan. 28, 2024			128,301,000
Beginning balance at Jan. 28, 2024		2,127,861	$ 1,284	587,960	1,555,595	(15,552)	(1,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		265,666			265,666
Foreign currency translation adjustments		(1,342)				(1,342)
Change in fair value of derivative financial instruments, net of tax		1				1
Conversion/release of stock-based awards (in shares)	[3]		687,000
Conversion/release of stock-based awards	[3]	(87,008)	$ 6	(86,787)			(227)
Repurchase of common stock (in shares)			(313,000)
Repurchase of common stock		(43,781)	$ (2)	(957)	(42,822)
Reissuance of treasury stock under stock-based compensation plans	[3]	0		(1,218)			1,218
Stock-based compensation expense		22,191		22,191
Dividends declared		(74,030)			(74,030)
Foreign currency translation adjustments		(1,342)
Ending balance (in shares) at Apr. 28, 2024			128,675,000
Ending balance at Apr. 28, 2024		2,209,558	$ 1,288	521,189	1,704,409	(16,893)	(435)
Beginning balance (in shares) at Jan. 28, 2024			128,301,000
Beginning balance at Jan. 28, 2024		2,127,861	$ 1,284	587,960	1,555,595	(15,552)	(1,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		740,364
Foreign currency translation adjustments		(1,404)
Change in fair value of derivative financial instruments, net of tax		1
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		94
Ending balance (in shares) at Oct. 27, 2024			123,876,000
Ending balance at Oct. 27, 2024		1,906,609	$ 1,239	545,205	1,377,461	(16,861)	(435)
Beginning balance (in shares) at Apr. 28, 2024			128,675,000
Beginning balance at Apr. 28, 2024		2,209,558	$ 1,288	521,189	1,704,409	(16,893)	(435)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		225,745			225,745
Foreign currency translation adjustments		(49)				(49)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		94				94
Conversion/release of stock-based awards (in shares)	[3]		35,000
Conversion/release of stock-based awards	[3]	(1,842)		(1,842)
Repurchase of common stock (in shares)	[4]		(922,000)
Repurchase of common stock	[4]	(130,518)	$ (10)	(2,808)	(127,700)
Stock-based compensation expense		21,633		21,633
Dividends declared		(74,391)			(74,391)
Foreign currency translation adjustments		(49)
Ending balance (in shares) at Jul. 28, 2024			127,788,000
Ending balance at Jul. 28, 2024		2,250,230	$ 1,278	538,172	1,728,063	(16,848)	(435)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		248,953			248,953
Foreign currency translation adjustments		(13)
Change in fair value of derivative financial instruments, net of tax		0
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		0
Conversion/release of stock-based awards (in shares)	[3]		17,000
Conversion/release of stock-based awards	[3]	(1,883)		(1,883)
Repurchase of common stock (in shares)	[4]		(3,929,000)
Repurchase of common stock	[4]	(539,149)	$ (39)	(12,155)	(526,955)
Stock-based compensation expense		21,071		21,071
Dividends declared		(72,600)			(72,600)
Foreign currency translation adjustments		(13)				(13)
Ending balance (in shares) at Oct. 27, 2024			123,876,000
Ending balance at Oct. 27, 2024		$ 1,906,609	$ 1,239	$ 545,205	$ 1,377,461	$ (16,861)	$ (435)

[1] Amounts are shown net of shares withheld for employee taxes.

[2] Repurchases of common stock include accrued excise taxes of $2.5 million as of October 29, 2023, which is recorded in retained earnings.

[3] Amounts are shown net of shares withheld for employee taxes.

[4] Repurchases of common stock include accrued excise taxes of $6.0 million as of October 27, 2024, which is recorded in retained earnings.